Useful, bounded context
We separate what a source states from what it can reasonably establish, and identify where uncertainty remains.
Independent resource / 01
Long Waypoint 72 exists to make complex, consequential information easier to assess without overstating what the evidence can support.
Why this resource exists / 02
Axiom Ember is an independent resource on ibogaine, heroin dependence, and opioid use disorder. It helps people distinguish early research, known risks, and established treatment options. The clinical brief at the center of this site is organized for readers who need context without promotional framing.
We separate what a source states from what it can reasonably establish, and identify where uncertainty remains.
The resource is built for people affected by opioid use disorder, families, researchers, and policymakers seeking clear context.
Our resource pathways show how material is grouped so readers can orient themselves before drawing conclusions.
Our editorial approach / 03
We use published literature, trial registries, and official public-health materials as general reference points. Trial entries can be checked against the ClinicalTrials.gov study registry, while public-health framing is compared with guidance from the CDC overdose prevention program.
Record whether material comes from literature, a registry, an official source, or a secondary account.
Keep study design, population, limits, and unresolved questions visible in the explanation.
Avoid turning preliminary information into certainty or presenting information as individualized advice.
What we cover / 04
Long Waypoint 72 gathers explanatory material into navigable sections: evidence, safety considerations, research orientation, and practical distinctions between kinds of sources. It also points outward when a narrower context may help, including material on ibogaine and brain injury and ibogaine clinical trials in Texas.
Adjacent topics are treated as separate contexts rather than interchangeable evidence. Readers encountering discussion of ibogaine as a psychedelic drug or ibogaine and alcohol addiction should keep source scope and stated limits in view.
Who this is for / 05
This resource is for people making sense of difficult material in different roles. The goal is not to direct an individual decision, but to make it easier to recognize the difference between an assertion, a source, and a supported conclusion.
Language stays direct, with attention to uncertainty, safety, and the limits of general information. Related material may include distinct contexts such as extreme alcoholism, without treating them as substitutes for one another.
We aim to preserve source context and avoid compressing nuanced evidence into a headline claim. Separate pages may address topics such as ibogaine treatment and depression where the underlying questions and evidence base differ.
Independent by design / 06
“Useful information should make its own boundaries visible.”
No. Long Waypoint 72 is an independent information resource, not a clinic, medical provider, or licensed treatment center. It does not provide medical or legal advice.
Use it as context for assessing sources and questions, not as a replacement for professional care or individualized guidance. For foundational terminology, the evidence-based medicine overview describes the value of integrating research evidence with clinical expertise and individual circumstances.
We prioritize traceable sourcing, plain language, explicit uncertainty, and safety clarity. Materials are structured to help readers distinguish established information from early or incomplete findings.
Long Waypoint 72
Explore the site’s structured material with the understanding that independent information is not a substitute for professional medical or legal advice.
Open the research guide →